Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Chronic Heart Failure

  Free Subscription


13.10.2025

5 Am Heart J
1 Cardiovasc Res
1 Circ Cardiovasc Qual Outcomes
1 Circ Genom Precis Med
2 Circ Heart Fail
1 Circ Res
3 Circulation
1 Eur Heart J
4 Eur J Heart Fail
1 Heart
1 Int J Cardiol
3 J Am Coll Cardiol
2 J Card Fail
1 J Cardiol
1 J Cardiovasc Pharmacol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. SZABO-SODERBERG B, Lund LH
    Response to letter by Naeem regarding article, "Loop and thiazide diuretics and outcomes in heart failure with preserved ejection fraction".
    Am Heart J. 2026;291:214-215.
    PubMed        

  2. NAEEM U, Qadir HA
    Letter to the editor: Loop and thiazide diuretics and outcomes in heart failure with preserved ejection fraction.
    Am Heart J. 2026;291:213.
    PubMed        

  3. OZONAT K, Centen C, Smith S, Aydemir B, et al
    Bioimpedance phase angle is associated with increased heart failure hospitalization risk.
    Am Heart J. 2025 Oct 6:107288. doi: 10.1016/j.ahj.2025.107288.
    PubMed         Abstract available

  4. HOLMEN S, Manintveld O, Damman K, Braun O, et al
    DAPAgliflozin for Renal protection in Heart Transplant recipients. Rationale and design of the randomized controlled DAPARHT trial.
    Am Heart J. 2025 Aug 19:S0002-8703(25)00300-X. doi: 10.1016/j.ahj.2025.
    PubMed         Abstract available

  5. ANNAPUREDDY AR, Murugiah K, Zheng L, Minges KE, et al
    Relationship between industry payments to physicians and prescription patterns for PCSK9is, ARNis and DOACs: A report from the NCDR PINNACLE registry.
    Am Heart J. 2026;291:26-36.
    PubMed         Abstract available


    Cardiovasc Res

  6. OBEIDAT M, Eisner DA
    A RADical approach to treating heart failure.
    Cardiovasc Res. 2025 Oct 10:cvaf184. doi: 10.1093.
    PubMed        


    Circ Cardiovasc Qual Outcomes

  7. KIDHOLM BOYSEN E, Kober L, Ersboll MK Prof, Kiilerich Lauridsen T, et al
    Trends in Guideline-Directed Medical Therapies and Clinical Management in Patients With Prevalent Versus Incident Heart Failure: A Danish Nationwide Study From 1996 to 2022.
    Circ Cardiovasc Qual Outcomes. 2025 Oct 9:e012117.
    PubMed        


    Circ Genom Precis Med

  8. REGAN JA, Franklin J, Kottilil K, Cauwenberghs N, et al
    CARS2 Hypermethylation Is a Risk Factor for Heart Failure: A Project Baseline Health Substudy.
    Circ Genom Precis Med. 2025 Oct 6:e005073. doi: 10.1161/CIRCGEN.125.005073.
    PubMed        


    Circ Heart Fail

  9. DANIEL V, Vardeny O
    Does Age Matter? SGLT2 Inhibitors in Older Adults With Heart Failure.
    Circ Heart Fail. 2025 Oct 10:e013595. doi: 10.1161/CIRCHEARTFAILURE.125.013595.
    PubMed        

  10. SHAH P, Zheng Y, Pieske B, Melenovsky V, et al
    Phenomapping in Heart Failure With Reduced Ejection Fraction to Identify Subpopulations With High Residual Risk: A VICTORIA Substudy.
    Circ Heart Fail. 2025 Oct 8:e013166. doi: 10.1161/CIRCHEARTFAILURE.125.013166.
    PubMed         Abstract available


    Circ Res

  11. PARTHIBAN P, Barrow F, Wang H, Chalise U, et al
    Macrophage-Derived CCL24 Promotes Cardiac Fibrosis Via Fibroblast CCR3.
    Circ Res. 2025;137:1140-1156.
    PubMed         Abstract available


    Circulation

  12. LUO S, Xu Y, Zhang S, Rooney MR, et al
    Two-Week Atrial Fibrillation Burden and Incident Heart Failure Among Older Individuals in the ARIC Study.
    Circulation. 2025;152:1037-1039.
    PubMed        

  13. CAMPAIN J, Griskowitz C, Newlands C, Claggett BL, et al
    Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial.
    Circulation. 2025;152:990-1002.
    PubMed         Abstract available

  14. GASPERETTI A, Muller SA, Peretto G, Asatryan B, et al
    Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants.
    Circulation. 2025;152:978-989.
    PubMed         Abstract available


    Eur Heart J

  15. GARCIA-PAVIA P, Gonzalez-Lopez E, Anderson LJ, Cappelli F, et al
    Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure Association.
    Eur Heart J. 2025 Oct 7:ehaf710. doi: 10.1093.
    PubMed         Abstract available


    Eur J Heart Fail

  16. KINOSHITA H, Sugino H, Kodama M, Saito M, et al
    The addition of vericiguat to sacubitril/valsartan improved the composite endpoint. Add a finishing touch on heart failure medical therapy by vericiguat as secret ingredient.
    Eur J Heart Fail. 2025 Oct 9. doi: 10.1002/ejhf.70059.
    PubMed        

  17. HOEVELMANN J, Markwirth P, Tokcan M, Haring B, et al
    What's new in heart failure? September 2025.
    Eur J Heart Fail. 2025;27:1603-1605.
    PubMed        

  18. ROMERO-GONZALEZ G, Husain-Syed F, Ronco C
    Letter regarding the article 'Urinary sodium analysis: The key to effective diuretic titration? European Journal of Heart Failure expert consensus document'.
    Eur J Heart Fail. 2025 Oct 5. doi: 10.1002/ejhf.70027.
    PubMed        

  19. MEEKERS E
    Reply to the letter regarding the article 'Urinary sodium analysis: The key to effective diuretic titration? European Journal of Heart Failure expert consensus document'.
    Eur J Heart Fail. 2025 Oct 5. doi: 10.1002/ejhf.70032.
    PubMed        


    Heart

  20. KILIC ME, Arayici ME, Yilancioglu RY, Turan OE, et al
    Frequent premature ventricular complexes and risk of atrial fibrillation, heart failure, stroke and mortality: a meta-analysis.
    Heart. 2025 Oct 6:heartjnl-2025-326174. doi: 10.1136/heartjnl-2025-326174.
    PubMed         Abstract available


    Int J Cardiol

  21. YANG L, Chen X, Fang Y, Chen D, et al
    Rate-adaptive pacing in right-sided heart failure with tricuspid regurgitation: A prospective pilot study.
    Int J Cardiol. 2025 Oct 6:133957. doi: 10.1016/j.ijcard.2025.133957.
    PubMed         Abstract available


    J Am Coll Cardiol

  22. RICCARDI M, Pabon MA, Vardeny O, Vaduganathan M, et al
    Reply: Heart Failure With Improved EF: A Transitional State Demanding Targeted Strategies?
    J Am Coll Cardiol. 2025;86:e135-e136.
    PubMed        

  23. LUO Y, Ghossein MA, Caliskan K
    Pharmacotherapy for Patients With Heart Failure and Improved Ejection Fraction: Updating Our Understanding.
    J Am Coll Cardiol. 2025;86:e131-e132.
    PubMed        

  24. GALLONE G, Baldetti L, Veen KM, Bernhardt AM, et al
    Trade-Off Between Bleeding and Ischemic Events From Left Ventricular Assist Devices: A EUROMACS Registry Analysis.
    J Am Coll Cardiol. 2025 Aug 21:S0735-1097(25)07381.
    PubMed         Abstract available


    J Card Fail

  25. SCHNEIDER SR, Lu H, Cikes M, Inciardi RM, et al
    Sleep Apnea and Cardiac Structure and Function in Patients with Heart Failure with Preserved Ejection Fraction: Insights from the PARAGON-HF Trial.
    J Card Fail. 2025 Oct 8:S1071-9164(25)00461.
    PubMed         Abstract available

  26. CHUNAWALA Z, Patel KV, Garcia KR, Keshvani N, et al
    Sex differences in NT-proBNP associations with risk of heart failure subtypes and response to an intensive lifestyle intervention in type 2 diabetes and overweight or obesity: a post-hoc analysis of the Look AHEAD trial: Sex differences, NT-proBNP, HF
    J Card Fail. 2025 Oct 5:S1071-9164(25)00464.
    PubMed        


    J Cardiol

  27. GAO J, Cao HS, Han L, Luo XQ, et al
    Association between insomnia symptoms and risk of heart failure: A meta-analysis of prospective cohort studies.
    J Cardiol. 2025 Oct 7:S0914-5087(25)00251-5. doi: 10.1016/j.jjcc.2025.
    PubMed         Abstract available


    J Cardiovasc Pharmacol

  28. NILO D, Gualdiero F, Russo V, Zielinska K, et al
    Commentary On the Effects of Anakinra on Cardiorespiratory Fitness in Heart Failure Stratified by Age in Phase II Clinical Trials.
    J Cardiovasc Pharmacol. 2025 Oct 10. doi: 10.1097/FJC.0000000000001767.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.